| Entry |
|
|---|
| Name |
Crilvastatin (USAN/INN) |
|---|
| Formula |
C14H23NO3
|
|---|
| Exact mass |
253.1678
|
|---|
| Mol weight |
253.3373
|
|---|
| Structure |
|
|---|
| Class |
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01660 HMG-CoA reductase inhibitor
|
|---|
| Efficacy |
Antihyperlipidemic, HMG-CoA reductase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG01660 HMG-CoA reductase inhibitor
D03601 Crilvastatin
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
HMGCR
D03601 Crilvastatin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C1y C 26.4322 -14.1081
2 N1x N 27.7323 -14.5837
3 C5x C 28.5852 -13.4914
4 C1x C 27.8100 -12.3427
5 C1x C 26.4780 -12.7251
6 C1y C 20.3533 -14.8103
7 C1x C 20.3533 -16.2185
8 C1z C 21.5728 -16.9226
9 C1x C 22.7924 -16.2185
10 C1y C 22.7924 -14.8103
11 C1x C 21.5728 -14.1062
12 O7a O 24.0307 -14.0951
13 C7a C 25.2430 -14.7949
14 O6a O 25.2434 -16.2181
15 C1a C 19.1338 -14.1062
16 O5x O 29.9554 -13.5383
17 C1a C 20.5828 -17.9125
18 C1a C 22.5627 -17.9125
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 6 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 10 11 1
11 6 11 1
12 12 13 1
13 13 14 2
14 10 12 1 #Up
15 6 15 1 #Up
16 1 13 1 #Down
17 3 16 2
18 8 17 1
19 8 18 1
|
|---|
